Precision Medicine
Precision Diagnostics. Advanced Insights. Better Outcomes.
Empowering clinicians and partners with accurate, fast, and clinically validated genetic insights – shaping the future of precision medicine across Asia.
Precision Medicine
Precision Diagnostics. Advanced Insights. Better Outcomes.
Empowering clinicians and partners with accurate, fast, and clinically validated genetic insights – shaping the future of precision medicine across Asia.
Quick Access
Quick Access to Clinical Testing
Navigate directly to our core somatic and
germine test offerings.
Why Oncode
Advanced diagnostics, clinically proven.
Navigate directly to our core somatic and
germine test offerings.
Unmatched Sensitivity
& Accuracy
Our diagnostic test are designed, validated, and continuously refined to achieve the highest precision — ensuring accurate mutation detection and clinically meaningful results for every patient.
Fast Turnaround.
Reliable Reporting
Optimised laboratory workflows and robust analysis pipelines enable consistent turnaround times, empowering clinicians to make timely and confident treatment decisions.
Trusted by Hospitals,
Pharma & Researchers
Oncode supports leading hospitals, universities, and pharmaceutical partners with dependable quality, strong clinical compliance, and scalable diagnostic solutions across the region.
Quality & Accreditation
Internationally Accredited, Globally Benchmarked. Consistently Proven
Oncode operates under stringent international
standards to ensure precision, consistency, and
clinical reliability in every diagnostic report.
Recognized by the College of American Pathologists for
meeting the highest standards in laboratory excellence
Quality & Accreditation
Internationally Accredited, Globally Benchmarked. Consistently Proven
Oncode operates under stringent international
standards to ensure precision, consistency, and
clinical reliability in every diagnostic report.
Accredited Medical Laboratory under the College of American Pathologists (CAP) and MS ISO 15189:2022 (SAMM No. 1137). Participant in international EQA programs including CAP PT, EMQN, and UK NEQAS.
CAP Accredited
College of American Pathologists
MS ISO 15189:2022
SAMM No. 1137
Active participant in
EMQN External Quality Assessment
Active participant in
UK NEQAS External Quality Assessment
One of Asia’s Early Precision
Medicine Centers
Advancing Precision Healthcare Since 2015
Trusted by Leading Hospitals, Institutions & Global Partners
Oncode collaborates with hospitals, pharmaceutical companies, universities, and research institutions across Asia to advance precision diagnostics and improve patient outcomes.
>100,000
Clinical molecular reports delivered
>500
Clinicians & specialists served
>250
Partnerships with hospitals, pharma & research institutions
>10
Active clinical trials & companion diagnostic collaborations
99.9%
Customer satisfaction rating
>10 years
Experience advancing precision diagnostics
